Recombinant Rat OX40/TNFRSF4 Fc Chimera Protein, CF Summary
Details of Functionality |
Measured by its binding ability in a functional ELISA. When recombinant rat OX40 Ligand is coated at 75 ng/mL (100 μL/well), the concentration of Recombinant OX40 Fc Chimera that produces 50% optimal binding response is 1-5 ng/mL. |
Source |
Mouse myeloma cell line, NS0-derived rat OX40/TNFRSF4 protein
Rat OX40/TNFRSF4 (Val20-Pro210) Accession # P15725 |
IEGRMDP |
Mouse IgG2a (Glu98-Lys330) |
N-terminus |
|
C-terminus |
|
|
Accession # |
|
N-terminal Sequence |
Val20 & Val22 |
Structure / Form |
Disulfide-linked homodimer |
Protein/Peptide Type |
Recombinant Proteins |
Gene |
Tnfrsf4 |
Purity |
>90%, by SDS-PAGE with silver staining |
Endotoxin Note |
<0.10 EU per 1 μg of the protein by the LAL method. |
Applications/Dilutions
Dilutions |
|
Theoretical MW |
48 kDa (monomer). Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
SDS-PAGE |
67-78 kDa reducing conditions |
Packaging, Storage & Formulations
Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 3 months, -20 to -70 °C under sterile conditions after reconstitution.
|
Buffer |
Lyophilized from a 0.2 μm filtered solution in PBS. |
Purity |
>90%, by SDS-PAGE with silver staining |
Reconstitution Instructions |
Reconstitute at 100 μg/mL in PBS. |
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Rat OX40/TNFRSF4 Fc Chimera Protein, CF
Background
OX40 (CD134; TNFRSF4) is a T cell co-stimulatory molecule of the TNF receptor superfamily that coordinates with other co-stimulators (CD28, CD40, CD30, CD27 and 4-1BB) to manage the activation of the immune response (1-3). Rat OX40 is a 50 kDa type I transmembrane glycoprotein with a 20 amino acid (aa) signal sequence, a 191 aa extracellular domain (ECD) that contains a cysteine-rich region, a 25 aa transmembrane segment, and a 36 aa cytoplasmic domain (4). The ECD of rat OX40 shares 90% and 63% sequence identity with the ECD of mouse and human OX40, respectively. OX40 is up-regulated on CD4
+ and CD8
+ T cells upon engagement of the TCR by antigen presenting cells along with co-stimulation by CD40-CD40 Ligand and CD28-B7 (5, 6). OX40 Ligand is primarily expressed on antigen presenting cells (5). OX40 Ligand engagement of OX40 on activated CD4
+ T cells results in increased T cell survival, proliferation, and cytokine production. It also inhibits the conversion of effector T cells into immunosuppressive regulatory T cells (Tregs) and can promote the maintenance of and recall response in memory T cells (3, 7-10). OX40 is constitutively expressed on Tregs and enhances the sensitivity of Tregs to IL-2, thus promoting Treg proliferation. OX40 has also been shown to decrease the cells’ immunosuppressive activity on effector T cells (11-14). OX40-OX40 Ligand signaling is involved in allergic airway inflammation, graft-versus-host disease and autoimmune disease (6, 15, 16). Mutations in OX40 and OX40 Ligand are associated with cardiovascular disease (17, 18).
- Hori, T. (2006) Int. J. Hematol. 83:17.
- Latza, U. et al. (1994) Eur. J. Immunol. 24:677.
- Salek-Ardakani, S. et al. (2003) J. Exp. Med. 198:315.
- al-Shamkhani, A. et al. (1996) Eur. J. Immunol. 26:1695.
- Moran, A.E. et al. (2013) Curr. Opin. Immunol. 25:230.
- Gramaglia, I. et al. (1998) J. Immunol. 161:6510.
- Xiao, X. et al. (2008) J. Immunol. 181:3193.
- So, T. and M. Croft (2007) J. Immunol. 179:1427.
- Mousavi, S.F. et al. (2008) J. Immunol. 181:5990.
- Bansal-Pakala, P. et al. (2001) Nat. Med. 7:907.
- Piconese, S. et al. (2010) Eur. J. Immunol. 40:2902.
- Griseri, T. et al. (2010) J. Exp. Med. 207:699.
- Xiao, X. et al. (2012) J. Immunol. 188:892.
- Vu, M.D. et al. (2007) Blood 110:2501.
- Damayanti, T. et al. (2010) Am. J. Respir. Crit. Care Med. 181:688.
- Xiao, X. et al. (2012) Nat. Immunol. 13:981.
- Nakano, M. et al. (2010) Cardiovasc. Res. 88:539.
- Ishii, N. et al. (2010) Adv. Immunol. 105:63.
Customers Who Viewed This Item Also Viewed...
Species: Hu
Applications: CyTOF-ready, Flow, ICC, Neut
Species: Hu
Applications: BA
Species: Ca, Hu, Mu, Po, Rb, Rt
Applications: Dual ISH-IHC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, Simple Western, WB
Species: Hu
Applications: CyTOF-ready, Flow, IHC, Neut, Simple Western, WB
Species: Hu
Applications: BA
Species: Hu
Applications: BA
Species: Mu, Rt
Applications: Cell Depl, CyTOF-ready, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, InhibTFunc
Species: Hu, Mu
Applications: Flow-IC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, WB
Species: Hu
Applications: CyTOF-ready, ELISA, Flow, ICC/IF, IHC, IHC-P, PA, WB
Species: Hu
Applications: AgAct, CyTOF-ready, ELISA(Cap), ELISA(Det), ELISA(Sta), Flow, ICC, IHC, Simple Western, WB
Species: Hu
Applications: AgAct, ICC, WB
Species: Hu
Applications: ELISA
Species: Hu
Applications: ELISA
Species: Hu
Applications: BA
Species: Hu
Applications: BA
Species: Hu
Applications: ELISA, ICC/IF, S-ELISA, WB
Species: Hu
Applications: Flow, Func, ICC/IF, IHC, IHC-Fr, IHC-P
Species: Mu
Applications: ELISA
Species: Hu
Applications: CyTOF-ready, Dual ISH-IHC, ELISA(Cap), ELISA(Det), ELISA(Sta), Flow, IHC, Neut
Species: Rt
Applications: Bioactivity
Publications for OX40/TNFRSF4 (8584-OX) (0)
There are no publications for OX40/TNFRSF4 (8584-OX).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for OX40/TNFRSF4 (8584-OX) (0)
There are no reviews for OX40/TNFRSF4 (8584-OX).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
FAQs for OX40/TNFRSF4 (8584-OX) (0)
Additional OX40/TNFRSF4 Products
Blogs on OX40/TNFRSF4